950 related articles for article (PubMed ID: 28953820)
1. Study on the prescribing patterns of antipsychotic medication in a rural England Community Mental Health Team.
Seshadri M; Elsemary A; Thalitaya MD; Chikodzore L; Nagalingam P
Psychiatr Danub; 2017 Sep; 29(Suppl 3):524-529. PubMed ID: 28953820
[TBL] [Abstract][Full Text] [Related]
2. Summary of the comparative effectiveness review on off-label use of atypical antipsychotics.
Maher AR; Theodore G
J Manag Care Pharm; 2012 Jun; 18(5 Suppl B):S1-20. PubMed ID: 22784311
[TBL] [Abstract][Full Text] [Related]
3. Atypical antipsychotics for psychosis in adolescents.
Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
Cochrane Database Syst Rev; 2013 Oct; (10):CD009582. PubMed ID: 24129841
[TBL] [Abstract][Full Text] [Related]
4. A Non-Interventional Naturalistic Study of the Prescription Patterns of Antipsychotics in Patients with Schizophrenia from the Spanish Province of Tarragona.
Gaviria AM; Franco JG; Aguado V; Rico G; Labad J; de Pablo J; Vilella E
PLoS One; 2015; 10(10):e0139403. PubMed ID: 26427051
[TBL] [Abstract][Full Text] [Related]
5. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
6. Prescribing of antipsychotics in UK primary care: a cohort study.
Marston L; Nazareth I; Petersen I; Walters K; Osborn DP
BMJ Open; 2014 Dec; 4(12):e006135. PubMed ID: 25524544
[TBL] [Abstract][Full Text] [Related]
7. [Guidelines for the prescription of mood stabilizers for adolescents: A literature review].
Munch G; Godart N
Encephale; 2017 Oct; 43(5):464-470. PubMed ID: 27871720
[TBL] [Abstract][Full Text] [Related]
8. Diagnoses associated with use of atypical antipsychotics in a commercial health plan: a claims database analysis.
Citrome L; Kalsekar I; Guo Z; Laubmeier K; Hebden T
Clin Ther; 2013 Dec; 35(12):1867-75. PubMed ID: 24119767
[TBL] [Abstract][Full Text] [Related]
9. The incidence, psychiatric co-morbidity and pharmacological treatment of severe mental disorders in children and adolescents.
Nesvåg R; Bramness JG; Handal M; Hartz I; Hjellvik V; Skurtveit S
Eur Psychiatry; 2018 Mar; 49():16-22. PubMed ID: 29366845
[TBL] [Abstract][Full Text] [Related]
10. Characteristics and the trajectory of psychotropic medication use in general and antipsychotics in particular among adults with an intellectual disability who exhibit aggressive behaviour.
Deb S; Unwin G; Deb T
J Intellect Disabil Res; 2015 Jan; 59(1):11-25. PubMed ID: 24450426
[TBL] [Abstract][Full Text] [Related]
11. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
Krzystanek M; Krupka-Matuszczyk I
Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
[TBL] [Abstract][Full Text] [Related]
12. The hidden magnitude of polypharmacy: using defined daily doses and maximum licensed daily doses to measure antipsychotic load.
Nguyen ML; Sunderland B; Lim S; Hattingh L; Chalmers L
Int J Clin Pharm; 2019 Dec; 41(6):1642-1651. PubMed ID: 31677120
[TBL] [Abstract][Full Text] [Related]
13. The prescription patterns of second-generation antipsychotics in schizophrenia outpatient setting.
Julaeha J; Athiyah U; Hermansyah A
J Basic Clin Physiol Pharmacol; 2019 Dec; 30(6):. PubMed ID: 31837257
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Unlicensed and Off-Label Use of Antipsychotics Prescribed to Child and Adolescent Psychiatric Outpatients for Treatment of Mental and Behavioral Disorders with Different Guidelines: The China Food and Drug Administration Versus the FDA.
Zhu X; Hu J; Sun B; Deng S; Wen Y; Chen W; Qiu C; Shang D; Zhang M
J Child Adolesc Psychopharmacol; 2018 Apr; 28(3):216-224. PubMed ID: 29336603
[TBL] [Abstract][Full Text] [Related]
15. Ethnicity and prescription patterns for haloperidol, risperidone, and olanzapine.
Opolka JL; Rascati KL; Brown CM; Gibson PJ
Psychiatr Serv; 2004 Feb; 55(2):151-6. PubMed ID: 14762239
[TBL] [Abstract][Full Text] [Related]
16. [Metabolic side effects of risperidone in early onset schizophrenia].
Goeb JL; Marco S; Duhamel A; Kechid G; Bordet R; Thomas P; Delion P; Jardri R
Encephale; 2010 Jun; 36(3):242-52. PubMed ID: 20620267
[TBL] [Abstract][Full Text] [Related]
17. An audit of outpatient antipsychotic usage in the three health sectors of Auckland, New Zealand.
Humberstone V; Wheeler A; Lambert T
Aust N Z J Psychiatry; 2004 Apr; 38(4):240-5. PubMed ID: 15038803
[TBL] [Abstract][Full Text] [Related]
18. Quetiapine versus other atypical antipsychotics for schizophrenia.
Asmal L; Flegar SJ; Wang J; Rummel-Kluge C; Komossa K; Leucht S
Cochrane Database Syst Rev; 2013 Nov; (11):CD006625. PubMed ID: 24249315
[TBL] [Abstract][Full Text] [Related]
19. Practice of prescribing antipsychotics in schizophrenia during 2013-2018 based on data from the National Health Fund.
Anczewska M; Balicki M; Droździkowska A; Gorczyca P; Janus J; Paciorek S; Plisko R; Zięba M
Psychiatr Pol; 2022 Aug; 56(4):751-766. PubMed ID: 37074827
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
